11th EUROPEAN BREAST CANCER CONFERENCE PARTICIPATION IN BARCELONA
11th European Breast Cancer Conference (EBCC-11),
March 21-23, 2018;
Accelsiors’ team will be joining scientific exchanges on all aspects of breast cancer clinical trials at the EBCC-11 meeting. Join us in Barcelona, 21-23 March 2018!
As one of the largest Breast Cancer Conference, the EBCC-11 provides an unique multidisciplinary setting for all professionals with common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape. Breast cancer stakeholders from over 90 countries will come together to share the most recent scientific knowledge.
We are pleased to be part of this professional debate on breast cancer. As a scientifically driven, global, full-service CRO, Accelsiors is experienced in oncology clinical trials with significant expertise in breast cancer clinical development. Our specialized medical experts and highly educated staff are experienced in all phases of clinical development, as we have designed, managed and monitored numerous clinical trials in breast and other gynaecological cancers from early to complex late phases around the globe.
We are delighted to invite you to meet us at EBCC-11 to discuss over a cup of coffee how our experience can be put to use in further developing your pipeline. Please send us an email to email@example.com and we will schedule a meeting around your calendar!
Accelsiors is proud to contribute to the research for curing of breast cancer and to support Pharma industry in finding new, more efficient and successful treatments on this terrible disease. Through our established relationship with oncologists and key recruiting sites for breast malignancies globally, we ensure the best screening and cost effective way of patient recruitment globally.
• For more information about the EBCC-11 Conference please click here!